Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.

Matrix metalloproteinase-7 (MMP-7), MMP-9, MMP-13, and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are considered to have important roles in the invasiveness and outcomes of colorectal cancer (CRC). This study examined the clinicopathological significance of the relative expression of these genes in patients with colorectal cancer, especially as related to liver metastasis. The study analysed surgical specimens of cancer tissue and adjacent normal mucosa obtained from 202 patients with untreated colorectal cancer. MMP-7, MMP-9, MMP-13, TIMP-1, and beta-actin mRNA of cancer tissue and adjacent normal mucosa were measured by quantitative real-time, reverse-transcriptase polymerase chain reaction. Expression levels of MMP-7, MMP-9, MMP-13 and TIMP-1 were higher in cancer tissue than in adjacent normal mucosa. On analysis of the relations between gene expression and clinicopathological factors, MMP-13 expression was found to correlate with liver metastasis. Moreover, MMP-13 expression levels were higher in tumour tissue with liver metastasis than in that without liver metastasis. It is concluded that MMP-13 gene expression is a useful predictor of liver metastasis in patients with CRC.

[1]  J. Guillem,et al.  Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer. , 1998, British Journal of Cancer.

[2]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[3]  S. Grénman,et al.  Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. , 1999, The American journal of pathology.

[4]  Ge Li,et al.  Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer , 2006, BMC Cancer.

[5]  Y. Okada,et al.  Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers , 1999, Gut.

[6]  J. Guillem,et al.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Grenman,et al.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. , 1997, The American journal of pathology.

[8]  S. Waldman,et al.  Tumor Epithelial Cell Matrix Metalloproteinase 9 Is a Target for Antimetastatic Therapy in Colorectal Cancer , 2006, Clinical Cancer Research.

[9]  W. Hornebeck,et al.  Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. , 2005, Biochimie.

[10]  Motoki Abe,et al.  Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. , 2008, The Journal of surgical research.

[11]  Hiroyuki Yamamoto,et al.  Interplay of Insulin-Like Growth Factor-II, Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, COX-2, and Matrix Metalloproteinase-7, Play Key Roles in the Early Stage of Colorectal Carcinogenesis , 2004, Clinical Cancer Research.

[12]  J. Guillem,et al.  Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  K. Geoghegan,et al.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.

[14]  Masaichi Ogawa,et al.  Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. , 2005, Hepato-gastroenterology.

[15]  C. López-Otín,et al.  Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). , 1997, European journal of biochemistry.

[16]  Z. Werb,et al.  Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix , 1995, Science.

[17]  B. Baldursson,et al.  Expression of matrix metalloproteinase (MMP)‐7 and MMP‐13 and loss of MMP‐19 and p16 are associated with malignant progression in chronic wounds , 2005, The British journal of dermatology.

[18]  L. Matrisian,et al.  Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. , 1996, The American journal of pathology.

[19]  N. Brünner,et al.  TIMP‐1 expression in human colorectal cancer is associated with TGF‐B1, LOXL2, INHBA1, TNF‐AIP6 and TIMP‐2 transcript profiles , 2008, Molecular oncology.

[20]  C. López-Otín,et al.  Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. , 1994, The Journal of biological chemistry.

[21]  E. Campo,et al.  Collagenase‐3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx , 1998 .

[22]  Z. Werb,et al.  Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene , 1996, The Journal of cell biology.

[23]  Edgar D Staren,et al.  Matrix metalloproteinase expression in breast cancer. , 2003, The Journal of surgical research.

[24]  S. Takao,et al.  Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas , 2002, Journal of surgical oncology.

[25]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[26]  O. Topolcan,et al.  Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. , 2007, Anticancer research.

[27]  N. Brünner,et al.  Tissue inhibitor of metalloproteinases-1 in breast cancer. , 2005, Endocrine-related cancer.

[28]  J. McKay,et al.  Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer , 2002, Journal of clinical pathology.

[29]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[30]  C. López-Otín,et al.  Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.

[31]  L. Matrisian,et al.  Matrix metalloproteinases in colorectal cancer: Is it worth talking about? , 2004, Cancer and Metastasis Reviews.

[32]  Fei Zhang,et al.  Tumor-derived Matrix Metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer , 2008, BMC Cancer.

[33]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[34]  K. Shirouzu,et al.  The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer , 2006, Cancer Chemotherapy and Pharmacology.

[35]  L. Liotta,et al.  Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.

[36]  A. Krüger,et al.  Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. , 2007, Cancer research.

[37]  W. Stetler-Stevenson.  Type IV collagenases in tumor invasion and metastasis , 1990, Cancer and Metastasis Reviews.

[38]  S. Kitano,et al.  Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness , 2000, Gut.

[39]  F. Vizoso,et al.  Collagenase-3 (MMP-13) Expression in Cutaneous Malignant Melanoma , 2005, The International journal of biological markers.

[40]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[41]  S. Curran,et al.  Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Phenotype Identifies Poor Prognosis Colorectal Cancers , 2004, Clinical Cancer Research.

[42]  P. Kronqvist,et al.  Association between high collagenase‐3 expression levels and poor prognosis in patients with head and neck cancer , 2006, Head & neck.

[43]  K. Imai,et al.  Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells , 1995, The Journal of Biological Chemistry.

[44]  K. Mimori,et al.  Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.

[45]  R. Grenman,et al.  Expression of collagenase-3 (MMP-13) by tumor cells in squamous cell carcinomas of the head and neck. , 1998, Advances in experimental medicine and biology.

[46]  V. Kähäri,et al.  Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets , 2002, International journal of cancer.

[47]  B. Nielsen,et al.  MMP-9 Is Differentially Expressed in Primary Human Colorectal Adenocarcinomas and Their Metastases , 2006, Molecular Cancer Research.

[48]  P. Boström,et al.  Expression of collagenase‐3 (matrix metalloproteinase‐13) in transitional‐cell carcinoma of the urinary bladder , 2000, International journal of cancer.

[49]  C. López-Otín,et al.  Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.

[50]  M. Chou,et al.  Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[51]  W. Stetler-Stevenson,et al.  In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. , 1998, The Journal of clinical investigation.

[52]  C. López-Otín,et al.  Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. , 1998, The Biochemical journal.

[53]  C. V. van Noorden,et al.  The role of gelatinases in colorectal cancer progression and metastasis. , 2004, Biochimica et biophysica acta.

[54]  K. Ohba,et al.  Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and Metastasis , 2006, Clinical Cancer Research.

[55]  P. Greenwald.  Colon cancer overview , 1992, Cancer.

[56]  J. Scoazec,et al.  Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain. , 2006, Cancer research.

[57]  E. Kerkelä,et al.  Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer , 2003, Experimental dermatology.